Publications by authors named "David Kingdon"

Claim this Profile
C
Childhood Trauma in Clozapine-Resistant Schizophrenia: Prevalence, and Relationship With Symptoms.
Robert Dudley, Douglas Turkington, Naomi Coulthard, Melissa Pyle, Andrew Gumley, David Kingdon

Schizophr Bull Open· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Positive Memory Training (PoMeT) for the Treatment of Depression in Schizophrenia.
Judit Simon, Noemi Kiss, Kees Korrelboom, David Kingdon, Til Wykes

Int J Environ Res Public Health· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The state of mental health care in China.
Ziyan Xu, Maximilian Gahr, Yutao Xiang, David Kingdon, Nicolas Rüsch

Asian J Psychiatr· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cultural Adaptations in Clinical InteractiONs (CoACtION): a multi-site comparative study to assess what cultural adaptations are made by clinicians in different settings.
Shanaya Rathod, Elizabeth Graves, David Kingdon, Kerensa Thorne, Farooq Naeem

Int Rev Psychiatry· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of a theoretically driven cognitive therapy (the Feeling Safe Programme) with befriending for the treatment of persistent persecutory delusions: a parallel, single-blind, randomised controlled trial.
Daniel Freeman, Richard Emsley, Rowan Diamond, Nicola Collett, Emily Bold, David Kingdon

Lancet Psychiatry· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of the mental health impact of SARS-CoV-2 on patients, general public and healthcare professionals: A systematic review and meta-analysis.
Peter Phiri, Rema Ramakrishnan, Shanaya Rathod, Kathryn Elliot, Tony Thayanandan, David Kingdon

EClinicalMedicine· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The revised Green , Paranoid Thoughts Scale (R-GPTS): psychometric properties, severity ranges, and clinical cut-offs.
Daniel Freeman, Bao S Loe, David Kingdon, Helen Startup, Andrew Molodynski

Psychol Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positive memory training for the treatment of depression in schizophrenia: A randomised controlled trial.
Craig Steel, Kees Korrelboom, M Fazil Baksh, David Kingdon, Judit Simon

Behav Res Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D-cycloserine augmentation of cognitive behavioral therapy for delusions: A randomized clinical trial.
Erica D Diminich, Faith Dickerson, Iruma Bello, Corinne Cather, David Kingdon

Schizophr Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health and Social Care Diversity Among Individuals with Longstanding Physical and Psychological Health Problems: Pooled Repeated Cross Sectional Analyses.
Corine Driessens, David Kingdon, David Pilgrim, Peter W F Smith

Community Ment Health J· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Dunn Worry Questionnaire and the Paranoia Worries Questionnaire: new assessments of worry.
Daniel Freeman, Jessica C Bird, Bao S Loe, David Kingdon, Helen Startup

Psychol Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refractory depression - mechanisms and efficacy of radically open dialectical behaviour therapy (RefraMED): findings of a randomised trial on benefits and harms.
Thomas R Lynch, Roelie J Hempel, Ben Whalley, Sarah Byford, Rampaul Chamba, David G Kingdon

Br J Psychiatry· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a prospective, mixed methods study to assess feasibility, acceptability and effectiveness of TRIumPH (Treatment and Recovery In PsycHosis): an integrated care pathway for psychosis, compared to usual treatment.
Shanaya Rathod, Kerensa Thorne, Elizabeth Graves, Peter Phiri, Carolyn Asher, David Kingdon

BMJ Open· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome-based providing and commissioning: pathways and standards.
David Kingdon

BJPsych Bull· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refractory depression - cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial.
James Shearer, Thomas R Lynch, Rampaul Chamba, Susan Clarke, Roelie J Hempel, David G Kingdon

BJPsych Open· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief cognitive-behavioural therapy for patients in the community with schizophrenia: Randomised controlled trial in Beijing, China - RETRACTION.
Zhi-Hua Guo, Zhan-Jiang Li, Yun Ma, Jing Sun, Jun-Hua Guo, David Kingdon

Br J Psychiatry· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Care programme approach - time to move beyond?
David Kingdon

BJPsych Bull· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT.
Anthony P Morrison, Melissa Pyle, Andrew Gumley, Matthias Schwannauer, Douglas Turkington, David Kingdon

Health Technol Assess· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive therapy of psychosis: Research and implementation.
David Kingdon, Douglas Turkington

Schizophr Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief cognitive-behavioural therapy for patients in the community with schizophrenia: Randomised controlled trial in Beijing, China - Expression of Concern.
Zhi-Hua Guo, Zhan-Jiang Li, Yun Ma, Jing Sun, Jun-Hua Guo, David Kingdon

Br J Psychiatry· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial.
Anthony P Morrison, Melissa Pyle, Andrew Gumley, Matthias Schwannauer, Douglas Turkington, David Kingdon

Lancet Psychiatry· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multinational comparative cross-sectional survey of views of medical students about acceptable terminology and subgroups in schizophrenia.
Shanaya Rathod, Muhammad Irfan, Rachna Bhargava, Narsimha Pinninti, Joseph Scott, David Kingdon

BMJ Open· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and potential pharmacological and psychosocial interventions for anxiety symptoms and disorders in patients with schizophrenia: structured review.
Fleur M Howells, David G Kingdon, David S Baldwin

Hum Psychopharmacol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis